{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:10:47Z","timestamp":1790863847355,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In the last decade, data has suggested that dietary advanced glycation end products (AGEs) play an important role in both reproductive and metabolic dysfunctions associated with polycystic ovary syndrome (PCOS). AGEs are highly reactive molecules that are formed by the non-enzymatic glycation process between reducing sugars and proteins, lipids, or nucleic acids. They can be formed endogenously under normal metabolic conditions or under abnormal situations such as diabetes, renal disease, and other inflammatory disorders. Bodily AGEs can also accumulate from exogenous dietary sources particularly when ingested food is cooked and processed under high-temperature conditions, such as frying, baking, or grilling. Women with PCOS have elevated levels of serum AGEs that are associated with insulin resistance and obesity and that leads to a high deposition of AGEs in the ovarian tissue causing anovulation and hyperandrogenism. This review will describe new data relevant to the role of AGEs in several key elements of PCOS phenotype and pathophysiology. Those elements include ovarian dysfunction, hyperandrogenemia, insulin resistance, and obesity. The literature findings to date suggest that targeting AGEs and their cellular actions could represent a novel approach to treating PCOS symptoms.<\/jats:p>","DOI":"10.3390\/nu14173578","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:13:56Z","timestamp":1661904836000},"page":"3578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-3813","authenticated-orcid":false,"given":"Marco","family":"Mouanness","sequence":"first","affiliation":[{"name":"Rejuvenating Fertility Center, New York, NY 10019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Nava","sequence":"additional","affiliation":[{"name":"Rejuvenating Fertility Center, New York, NY 10019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dagher","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut P.O. Box 100, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher","family":"Merhi","sequence":"additional","affiliation":[{"name":"Rejuvenating Fertility Center, New York, NY 10019, USA"},{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA"},{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY 11219, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajo.12730","article-title":"Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16-29 years","volume":"58","author":"Varanasi","year":"2018","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.18544\/PEDM-24.01.0101","article-title":"Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty","volume":"24","author":"Grzyb","year":"2018","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Group TREAsPcw (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"(2018). Committee on Practice Bulletins- Gynecology, Polycystic Ovary Syndrome: ACOG Practice Bulletin, Number 194. Obstet. Gynecol., 131, 1174\u20131176.","DOI":"10.1097\/AOG.0000000000002657"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","article-title":"Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways","volume":"274","author":"Huttunen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humrep\/det383","article-title":"Advanced glycation end products and their relevance in female reproduction","volume":"29","author":"Merhi","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/eye.1993.55","article-title":"The Maillard or browning reaction in diabetes","volume":"7","author":"John","year":"1993","journal-title":"Eye"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/EBC20190057","article-title":"Dicarbonyl derived post-translational modifications: Chemistry bridging biology and aging-related disease","volume":"64","author":"Sibbersen","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.patbio.2009.09.014","article-title":"The Maillard reaction in the human body. The main discoveries and factors that affect glycation","volume":"58","author":"Tessier","year":"2010","journal-title":"Pathol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2892","DOI":"10.1002\/dmrr.2892","article-title":"Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: The NQplus study","volume":"33","author":"Botros","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes","volume":"57","author":"Watson","year":"2008","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Katsikis","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Piperi","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.3390\/nu7125524","article-title":"Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?","volume":"7","author":"Garg","year":"2015","journal-title":"Nutrients"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gill, V., Kumar, V., Singh, K., Kumar, A., and Kim, J.J. (2019). Advanced Glycation End Products (AGEs) May Be a Striking Link between Modern Diet and Health. Biomolecules, 9.","DOI":"10.3390\/biom9120888"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Guilbaud, A., Niquet-Leridon, C., Boulanger, E., and Tessier, F.J. (2016). How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?. Foods, 5.","DOI":"10.3390\/foods5040084"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bettiga, A., Fiorio, F., Di Marco, F., Trevisani, F., Romani, A., Porrini, E., Salonia, A., Montorsi, F., and Vago, R. (2019). The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology. Nutrients, 11.","DOI":"10.3390\/nu11081748"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00109-007-0246-6","article-title":"Accumulation of dietary glycotoxins in the reproductive system of normal female rats","volume":"85","author":"Piperi","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/157489007780832498","article-title":"Methylglyoxal and advanced glycation endproducts: New therapeutic horizons?","volume":"2","author":"Desai","year":"2007","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","article-title":"Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries","volume":"127","author":"Piperi","year":"2007","journal-title":"Histochem. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.2174\/1381612822666160714094404","article-title":"Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?","volume":"22","author":"Rutkowska","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","author":"Zhang","year":"2015","journal-title":"Metabolism"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2018.08.010","article-title":"Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS","volume":"479","author":"Merhi","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","article-title":"RAGE: A novel biological and genetic marker for vascular disease","volume":"116","author":"Kalea","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fertnstert.2012.11.029","article-title":"The aging ovary--the poor granulosa cells","volume":"99","author":"Tatone","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2009.03.029","article-title":"The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: The influence of aging","volume":"94","author":"Fujii","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/geno.1994.1517","article-title":"Three genes in the human MHC class III region near the junction with the class II: Gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3","volume":"23","author":"Sugaya","year":"1994","journal-title":"Genomics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biocel.2014.10.001","article-title":"The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors","volume":"57","author":"Meghnani","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F645","DOI":"10.1152\/ajprenal.00398.2004","article-title":"Advanced glycation end products and the kidney","volume":"289","author":"Bohlender","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/bmc-2016-0021","article-title":"Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy","volume":"7","author":"Chitra","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic Toxicity of Advanced Glycation End Products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1535370217731288","article-title":"Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells","volume":"243","author":"Kandaraki","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1074\/jbc.M115.667576","article-title":"Advanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor \u03baB (NF-\u03baB)","volume":"291","author":"Verma","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Empsen","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1043-2760(03)00005-5","article-title":"Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family","volume":"14","author":"Josso","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0303-7207(01)00467-1","article-title":"Anti-Mullerian hormone and its receptors","volume":"179","author":"Josso","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: A mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.fertnstert.2015.07.325","article-title":"Vitamin D attenuates the adverse effect of advanced glycation end products on human granulosa cells: Implications for women with PCOS","volume":"104","author":"Merhi","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"L1094","DOI":"10.1152\/ajplung.00318.2007","article-title":"RAGE: Developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells","volume":"294","author":"Reynolds","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/humrep\/deh389","article-title":"Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts","volume":"19","author":"Konishi","year":"2004","journal-title":"Hum. Reprod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"101958","DOI":"10.1016\/j.redox.2021.101958","article-title":"The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes","volume":"42","author":"Erusalimsky","year":"2021","journal-title":"Redox Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/REP-16-0359","article-title":"Decreased levels of sRAGE in follicular fluid from patients with PCOS","volume":"153","author":"Wang","year":"2017","journal-title":"Reproduction"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.011","article-title":"Soluble RAGEs-Prospects for treating & tracking metabolic and inflammatory disease","volume":"72","author":"Schmidt","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db12-1528","article-title":"sRAGE and risk of diabetes, cardiovascular disease, and death","volume":"62","author":"Selvin","year":"2013","journal-title":"Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/09513590.2021.1942453","article-title":"sRAGE downregulates the VEGF expression in OHSS ovarian granulosa cells","volume":"37","author":"Wang","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/molehr\/gay014","article-title":"Advanced glycation end products alter steroidogenic gene expression by granulosa cells: An effect partially reversible by vitamin D","volume":"24","author":"Merhi","year":"2018","journal-title":"Mol. Hum. Reprod."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2005-2559","article-title":"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein","volume":"91","author":"Basta","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10815-016-0704-6","article-title":"Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): A potential protective role in polycystic ovary syndrome","volume":"33","author":"Wang","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s10815-017-1011-6","article-title":"Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS","volume":"34","author":"Garg","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0945-053X(98)90012-9","article-title":"Lysyl oxidase: Properties, regulation and multiple functions in biology","volume":"16","author":"Kagan","year":"1998","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/endo.142.3.7990","article-title":"Differentiation-dependent expression of connective tissue growth factor and lysyl oxidase messenger ribonucleic acids in rat granulosa cells","volume":"142","author":"Slee","year":"2001","journal-title":"Endocrinology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1095\/biolreprod64.1.157","article-title":"Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats","volume":"64","author":"Endo","year":"2001","journal-title":"Biol. Reprod."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/j.1582-4934.2009.00841.x","article-title":"Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue","volume":"14","author":"Papachroni","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2119\/molmed.2012.00293","article-title":"Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: A causative link to polycystic ovarian syndrome","volume":"18","author":"Kandaraki","year":"2012","journal-title":"Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF03401321","article-title":"Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)","volume":"13","author":"Tantalaki","year":"2014","journal-title":"Hormones"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lin, P.-H., Chang, C.-C., Wu, K.-H., Shih, C.-K., Chiang, W., Chen, H.-Y., Wang, K.-L., Hong, Y.-H., Shieh, T.-M., and Hsia, S.-M. (2019). Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms. Biomolecules, 9.","DOI":"10.3390\/biom9080327"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.fertnstert.2016.07.224","article-title":"Vitamin d reverses the adverse effects of advanced glycation end products on granulosa cells","volume":"106","author":"Merhi","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/JOE-13-0175","article-title":"Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats","volume":"218","author":"Chatzigeorgiou","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"bqaa015","DOI":"10.1210\/endocr\/bqaa015","article-title":"Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS","volume":"161","author":"Azhary","year":"2020","journal-title":"Endocrinology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","article-title":"Insulin resistance and PCOS: Chicken or egg?","volume":"44","author":"Moghetti","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11, PMCID: PMC6836220.","DOI":"10.3390\/nu11102278"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3945\/ajcn.115.125427","article-title":"Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: A double-blind, randomized, crossover trial","volume":"103","author":"Soldatos","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2009-0089","article-title":"Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: Role of the antiinflammatory AGE receptor-1","volume":"94","author":"Vlassara","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrendo.2011.74","article-title":"AGE restriction in diabetes mellitus: A paradigm shift","volume":"7","author":"Vlassara","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1073\/pnas.1205847109","article-title":"Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1","volume":"109","author":"Cai","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/dc13-0842","article-title":"Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women","volume":"37","author":"Mark","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41598-017-02268-0","article-title":"Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: Meta-analysis of randomised controlled trials","volume":"7","author":"Baye","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40618-018-0944-7","article-title":"Effects of selenium and vitamin C on the serum level of antithyroid peroxidase antibody in patients with autoimmune thyroiditis","volume":"42","author":"Karimi","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.diabres.2018.11.016","article-title":"Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review","volume":"148","author":"Jud","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bbadis.2019.02.011","article-title":"SIRT1 participates in the response to methylglyoxal-dependent glycative stress in mouse oocytes and ovary","volume":"1865","author":"Santini","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_81","first-page":"2511","article-title":"Reduction of serum advanced glycation end-products with a low calorie Mediterranean diet","volume":"31","author":"Concha","year":"2015","journal-title":"Nutr. Hosp."},{"key":"ref_82","first-page":"340","article-title":"Mediterranean Diet Supplemented with Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women","volume":"73","author":"Camargo","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s394-001-8356-3","article-title":"Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet","volume":"40","author":"Schinzel","year":"2001","journal-title":"Eur. J. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.patbio.2006.07.006","article-title":"Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes","volume":"54","author":"Peyroux","year":"2006","journal-title":"Pathol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.drudis.2006.05.016","article-title":"Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases","volume":"11","author":"Reddy","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar2700","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes","volume":"11","author":"Rasheed","year":"2009","journal-title":"Arthritis Res. Ther."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:11Z","timestamp":1760142011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":86,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["nu14173578"],"URL":"https:\/\/doi.org\/10.3390\/nu14173578","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}